Houston blockchain startup partners with software company for COVID-19 test kit tracking
pandemic innovating
A Houston-based blockchain network developer has established a partnership with an Austin-based developer to track and trace COVID-19 test kits.
Topl and Media Sourcery Inc. announced this week that they are teaming up to jointly develop and launch various blockchain-powered platforms. The first of the projects will use Topl's impact-focused blockchain with MSI's workflow automation and security tools in a health care application involved in tracking test kits for COVID-19.
With a goal of increasing transparency while maintaining security, Topl and MSI's test kit tracking process can provide results to those who need them while remaining HIPAA compliant and secure.
"Identity solutions are extremely important to the blockchain community," says Kim Raath, CEO of Topl, in a press release. "Blockchain technology is uniquely suited to prove identity and make authorizations more secure. This is something that will be particularly useful in healthcare applications, as we can be guaranteed that patient data and medical information remains private, secured, and tracked, as opposed to some current methods that are not able match patient identities with patient procedures and treatments."
Two health care companies are already involved in the project. California-based Achieve Health Management will be the distributor of the kits and Osang Healthcare, the first South Korean firm to receive FDA approval for COVID-19 test kit distribution in the United States, will be the test kit manufacturer.
"The transparency of having a shared public ledger for the transport, storage, and handling events of the GeneFinder COVID-19 Plus RealAmp Tests will provide unprecedented assurance to our labs, customers and test populations," says Stacy Chick, chief commercial officer for Achieve Health Management, in the release. "This application will also help ensure our end-to-end process provides proper test kit handling and storage in temperature-controlled environments for optimal test performance".
Topl and MSI have plans for other COVID-related projects, including tracking vaccines as they continue to be developed and eventually distributed.
"The technology under our non-repudiation patent provides a layer of certified trust," says Larry Ketchersid, CEO of MSI, in the release. "Combining that solution with the immutability and shared public ledger provided by the Topl blockchain-as-a-service solution will give our customers the highest level of transparency, visibility and trust."